Company Biophytis S.A.

Equities

ALBPS

FR001400OLP5

Biotechnology & Medical Research

Real-time Euronext Paris 08:10:25 2024-07-12 am EDT 5-day change 1st Jan Change
0.575 EUR 0.00% Intraday chart for Biophytis S.A. -0.86% -71.81%

Business Summary

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Number of employees: 22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,601,206 1,055,663 ( 40.58 %) 600 ( 0.0231 %) 40.58 %

Shareholders

NameEquities%Valuation
81,939 1.559 % 51 812 €
Gestys SA
1.065 %
55,950 1.065 % 35 379 €
Waly Dioh
0.0117 %
616 0.0117 % 390 €
Pierre Dilda
0.006775 %
356 0.006775 % 225 €
Rob van Maanen
0.003616 %
190 0.003616 % 120 €
190 0.003616 % 120 €
Nadine Coulm
0.000057 %
3 0.000057 % 2 €
Claude Allary
0.000000 %
0 0.000000 % - €
Jean Mariani
0.000000 %
0 0.000000 % - €
NameEquities%Valuation
GAMMA Investing LLC
0.1885 %
662 0.1885 % 4 186 €
UBS Securities LLC
0.005126 %
18 0.005126 % 114 €
RhumbLine Advisers LP
0.003702 %
13 0.003702 % 82 €

Company contact information

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com
address Biophytis S.A.(ALBPS)
  1. Stock Market
  2. Equities
  3. ALBPS Stock
  4. Company Biophytis S.A.